HT (B-Cell Lymphoma) Cell Lines

HT (B-cell lymphoma) control cell line and TNF receptor associated factor 6 (TRAF6) Knock Down HT (B-Cell Lymphoma) Cell Line were stablished from the ascitic effusion of a 70-year-old man with B cell non-Hodgkin lymphoma (B-NHL) in 1983 (diffuse large cell lymphoma).

B-Cell lymphoma is a cancer that forms in white blood cells called lymphocytes. Most B-cell lymphomas are non-Hodgkin's lymphoma. TNF receptor associated factors also known as TRAFs are a family of proteins primarily involved in the regulation of inflammation, antiviral responses and apoptosis. There are 7 mammalian TRAFs and they mediates interactions with other signaling components such as the transmembrane TNF receptors and CD40.

From the laboratory of Francisco Vega, MD, PhD, University of Miami.

Catalog Number Product DataSheet Size AVAILABILITY Price Qty
EMI026
TRAF6 Knock Down HT (B-Cell Lymphoma) Cell Line
1 Vial 4-6 weeks
Regular Price:$580.00
On Sale:
EMI025
HT (B-Cell Lymphoma) Control Cell Line
1 Vial 4-6 weeks
Regular Price:$580.00
On Sale:
Specifications

Product Type: Cell Line
Cell Type: HT (B-cell lymphoma)
TRAF6 Knock Down HT (B-Cell Lymphoma)
Morphology: Suspension
Organism: Human
Source: Ascitic effusion
Biosafety Level: BSL 2
Growth Conditions: RPMI+10% FBS+ Antibiotics + 1µg/ml puromycin
Subculturing: Doubling time 30-40hrs
Cryopreservation: 95% complete media + 5% DMSO
Age: 70-year-old male
Comments: 1ug/mL puromycin reuired for selection.
Storage: Liquid Nitrogen
Shipped: Dry Ice

Provider

From the laboratory of Francisco Vega, MD, PhD, University of Miami.

References
  1. Qu C, Kunkalla K, Vaghefi A, Frederiksen JK, Liu Y, Chapman JR, Blonska M, Bernal-Mizrachi L, Alderuccio JP, Lossos IS, Landgraf R, Vega F. Smoothened stabilizes and protects TRAF6 from degradation: A novel non-canonical role ofsmoothened with implications in lymphoma biology. Cancer Lett. 2018 Nov 1;436:149-158.

If you publish research with this product, please let us know so we can cite your paper.

Loading...